ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Medical Director at 4D Molecular Therapeutics - ApplyBlast

Medical Director

4D Molecular Therapeutics

4 months ago

3.8 on Glassdoor

United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Medical Director leads the design, execution, and analysis of clinical trials within the ophthalmology therapeutic area, specifically focusing on retina programs. This strategic role provides operational clinical leadership across cross-functional teams, serving as a key medical expert for internal and external stakeholders while overseeing protocol development and patient safety. The position involves engaging with regulatory bodies, organizing advisory boards, and driving the success of late-stage biotechnology programs such as those for age-related macular degeneration and cystic fibrosis.

Responsibilities

Lead clinical strategy and execution for ophthalmology trials
Serve as medical monitor ensuring patient safety and data integrity
Author and review clinical documents including protocols and regulatory submissions
Collaborate with cross-functional teams to drive program success
Engage with external experts to contribute to scientific communications

Skills

Qualifications

Medical Degree (M.D.)ODPhDPharmDBoard Certification

About 4D Molecular Therapeutics

4dmoleculartherapeutics.com

Headquarters

Emeryville, California, United States

Company Size

51-200 employees

Founded

2013

View Profile

4D Molecular Therapeutics (4DMT) is a clinical-stage biotechnology company that designs, develops, and commercializes gene therapies for serious, unmet medical conditions. Using a proprietary AAV capsid engineering and targeted delivery platform, 4DMT creates vectors optimized for tissue specificity, potency, and manufacturability to improve safety and therapeutic benefit. The company focuses on translational programs across ocular, neuromuscular, central nervous system, and cardiopulmonary indications and partners to advance candidates toward clinical and commercial development.